Stem Cells and Ischemia/Wound Healing: Here We Come? Results from RESTORE phase 2 study

We look forward to Phase 3.

Final Results from RESTORE-CLI Phase 2b Clinical Trial for Ixmyelocel-T in Treatment of Critical Limb Ischemia Published in the Peer-Reviewed Journal Molecular Therapy – MarketWatch:

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Up ↑

Discover more from DF Blog

Subscribe now to keep reading and get access to the full archive.

Continue reading

Verified by MonsterInsights